These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38003732)

  • 1. Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection.
    Locatelli M; Rottoli D; Mahmoud R; Abbate M; Corna D; Cerullo D; Tomasoni S; Remuzzi G; Zoja C; Benigni A; Macconi D
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Endothelial Glycocalyx on Peritubular Capillaries in Chronic Kidney Disease.
    Ermert K; Buhl EM; Klinkhammer BM; Floege J; Boor P
    Am J Pathol; 2023 Feb; 193(2):138-147. PubMed ID: 36414084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
    Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
    Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
    Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
    Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting mimicking diet in diabetic mice partially preserves glomerular endothelial glycocalyx coverage, without changing the diabetic metabolic environment.
    van der Velden AIM; Koudijs A; Kooijman S; Rietjens RGJ; Sol WMPJ; Avramut MC; Wang G; Rensen PCN; Rabelink TJ; van der Vlag J; van den Berg BM
    Am J Physiol Renal Physiol; 2024 May; 326(5):F681-F693. PubMed ID: 38205540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.
    Bábíčková J; Klinkhammer BM; Buhl EM; Djudjaj S; Hoss M; Heymann F; Tacke F; Floege J; Becker JU; Boor P
    Kidney Int; 2017 Jan; 91(1):70-85. PubMed ID: 27678159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.
    Hamar P; Kerjaschki D
    Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H981-H990. PubMed ID: 27496878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway.
    Locatelli M; Zoja C; Conti S; Cerullo D; Corna D; Rottoli D; Zanchi C; Tomasoni S; Remuzzi G; Benigni A
    J Pathol; 2022 Apr; 256(4):468-479. PubMed ID: 35000230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
    Cassis P; Locatelli M; Corna D; Villa S; Rottoli D; Cerullo D; Abbate M; Remuzzi G; Benigni A; Zoja C
    Kidney Int; 2019 Oct; 96(4):906-917. PubMed ID: 31307778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dual PPAR
    Ericsson A; Tonelius P; Lal M; Sabirsh A; Böttcher G; William-Olsson L; Strömstedt M; Johansson C; Hyberg G; Tapani S; Jönsson-Rylander AC; Unwin R
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier.
    Ando Y; Okada H; Takemura G; Suzuki K; Takada C; Tomita H; Zaikokuji R; Hotta Y; Miyazaki N; Yano H; Muraki I; Kuroda A; Fukuda H; Kawasaki Y; Okamoto H; Kawaguchi T; Watanabe T; Doi T; Yoshida T; Ushikoshi H; Yoshida S; Ogura S
    Sci Rep; 2018 Nov; 8(1):17523. PubMed ID: 30504908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions.
    Okada H; Takemura G; Suzuki K; Oda K; Takada C; Hotta Y; Miyazaki N; Tsujimoto A; Muraki I; Ando Y; Zaikokuji R; Matsumoto A; Kitagaki H; Tamaoki Y; Usui T; Doi T; Yoshida T; Yoshida S; Ushikoshi H; Toyoda I; Ogura S
    Crit Care; 2017 Oct; 21(1):261. PubMed ID: 29058634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
    Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
    Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id1 expression in kidney endothelial cells protects against diabetes-induced microvascular injury.
    Sharma S; Plotkin M
    FEBS Open Bio; 2020 Aug; 10(8):1447-1462. PubMed ID: 31957231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy.
    Desideri S; Onions KL; Baker SL; Gamez M; El Hegni E Hussien H; Russell A; Satchell SC; Foster RR
    Biorheology; 2019; 56(2-3):163-179. PubMed ID: 31156139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
    Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
    Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
    J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha.
    Yuan HT; Li XZ; Pitera JE; Long DA; Woolf AS
    Am J Pathol; 2003 Dec; 163(6):2289-301. PubMed ID: 14633603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
    Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.